ArticleTranslational psychiatry2025
Modulation of suicide-related neural circuits by transcranial magnetic stimulation and its role in reducing suicide risk.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Suicide remains a critical public health issue, frequently linked to dysfunction in specific neural circuits. Disruption of these circuits may contribute to the onset of suicide. Accordingly, this study investigates the therapeutic potential of transcranial magnetic stimulation (TMS) in modulating suicide-related damaged networks. A total of 473 major depressive disorder patients were included, comprising 369 suicidal and 104 non-suicidal individuals. Deviations in functional connectivity strength (FCS) within the suicide-related damaged network were calculated using a normative model based on 943 healthy controls. Suicidal patients showed significantly higher deviations within the suicide-related damaged network compared to non-suicidal patients (z = 3.02, p = 0.003). Following TMS treatment, the mean deviations significantly decreased (z = 2.23, p = 0.026), particularly in responders (z = 2.29, p = 0.020). Furthermore, a classifier based on these deviations predicted treatment response with an accuracy of 75% and an area under the curve of 0.72. These findings suggest that deviations in FCS may serve as a neural marker of suicide risk and a potential predictor of treatment response to TMS. TMS may reduce suicide risk by modulating neuroplasticity within the suicide-related damaged network.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.